112 related articles for article (PubMed ID: 31439496)
1. Effectiveness of pneumococcal conjugate vaccine against hospital admissions for pneumonia in Australian children: a retrospective, population-based, record-linked cohort study.
Fathima P; Gidding HF; McIntyre PB; Snelling TL; McCallum L; de Klerk N; Blyth CC; Liu B; Moore HC
Lancet Child Adolesc Health; 2019 Oct; 3(10):713-724. PubMed ID: 31439496
[TBL] [Abstract][Full Text] [Related]
2. Incremental effectiveness of 23-valent pneumococcal polysaccharide vaccine against pneumonia hospitalisation among Australian Indigenous children: A record linkage study.
Kabir A; Randall D; Newall AT; Moore HC; Jayasinghe S; Fathima P; Liu B; McIntyre P; Gidding HF
Vaccine; 2023 Aug; 41(37):5454-5460. PubMed ID: 37507273
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of 13-valent pneumococcal conjugate vaccine on all-cause pneumonia in children under 5 years in Shanghai, China: An observational study.
Tian J; Zheng B; Yang L; Guan Y; Xu C; Wang W
Vaccine; 2023 Sep; 41(41):5979-5986. PubMed ID: 37620204
[TBL] [Abstract][Full Text] [Related]
4. Effect of the PCV 10 vaccination on community-acquired pneumonia hospitalisations after four years of its introduction into the Polish National Immunisation Programme: Follow-up study.
Gajewska M; Lewtak K; Goryński P; Piotrowicz M; Urban E; Paradowska-Stankiewicz I; Rutyna A; Nitsch-Osuch A
Vaccine; 2024 May; 42(13):3257-3262. PubMed ID: 38641493
[TBL] [Abstract][Full Text] [Related]
5. Effect of 10-valent pneumococcal conjugate vaccine on the incidence of radiologically-confirmed pneumonia and clinically-defined pneumonia in Kenyan children: an interrupted time-series analysis.
Silaba M; Ooko M; Bottomley C; Sande J; Benamore R; Park K; Ignas J; Maitland K; Mturi N; Makumi A; Otiende M; Kagwanja S; Safari S; Ochola V; Bwanaali T; Bauni E; Gleeson F; Deloria Knoll M; Adetifa I; Marsh K; Williams TN; Kamau T; Sharif S; Levine OS; Hammitt LL; Scott JAG
Lancet Glob Health; 2019 Mar; 7(3):e337-e346. PubMed ID: 30784634
[TBL] [Abstract][Full Text] [Related]
6. Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States.
Wiese AD; Griffin MR; Grijalva CG
Expert Rev Vaccines; 2019 Apr; 18(4):327-341. PubMed ID: 30759352
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of PCV13 against all-cause hospitalized pneumonia in children in Beijing, China: real-world evidence.
Lv M; Du J; Xie MZ; Zhou Y; Yang G; Wang J; Zhang WX; Yang H; Zhang SS; Cui F; Lu QB; Wu J
Vaccine; 2024 Apr; 42(12):3091-3098. PubMed ID: 38594120
[TBL] [Abstract][Full Text] [Related]
8. Decreased diarrheal and respiratory disease in HIV exposed uninfected children following vaccination with rotavirus and pneumococcal conjugate vaccines.
Ajibola G; Bennett K; Powis KM; Hughes MD; Leidner J; Kgole S; Batlang O; Mmalane M; Makhema J; Lockman S; Shapiro R
PLoS One; 2020; 15(12):e0244100. PubMed ID: 33347474
[TBL] [Abstract][Full Text] [Related]
9. Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia.
Loo JD; Conklin L; Fleming-Dutra KE; Deloria Knoll M; Park DE; Kirk J; Goldblatt D; O'Brien KL; Whitney CG
Pediatr Infect Dis J; 2014 Jan; 33 Suppl 2(Suppl 2 Optimum Dosing of Pneumococcal Conjugate Vaccine For Infants 0 A Landscape Analysis of Evidence Supportin g Different Schedules):S140-51. PubMed ID: 24336056
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of 7-valent pneumococcal conjugate vaccine against radiologically diagnosed pneumonia in indigenous infants in Australia.
O'Grady KF; Carlin JB; Chang AB; Torzillo PJ; Nolan TM; Ruben A; Andrews RM
Bull World Health Organ; 2010 Feb; 88(2):139-46. PubMed ID: 20428371
[TBL] [Abstract][Full Text] [Related]
11. Real world impact of 13vPCV in preventing invasive pneumococcal pneumonia in Australian children: A national study.
Homaira N; Strachan R; Quinn H; Beggs S; Bhuiyan M; Bowen A; Fawcett LK; Gilbert GL; Lambert SB; Macartney K; Marshall HS; Martin Md AC; McCallum G; McCullagh A; McDonald T; Selvadurai H; McIntyre P; Oftadeh S; Ranganathan PhD S; Saunders T; Suresh S; Wainwright C; Wilson A; Wong M; Jaffe A; Snelling T
Vaccine; 2023 Jan; 41(1):85-91. PubMed ID: 36400662
[TBL] [Abstract][Full Text] [Related]
12. Pneumonia hospitalisation and case-fatality rates in older Australians with and without risk factors for pneumococcal disease: implications for vaccine policy.
Dirmesropian S; Liu B; Wood JG; MacIntyre CR; McIntyre P; Karki S; Jayasinghe S; Newall AT
Epidemiol Infect; 2019 Jan; 147():e118. PubMed ID: 30869015
[TBL] [Abstract][Full Text] [Related]
13. Inequalities in pediatric avoidable hospitalizations between Aboriginal and non-Aboriginal children in Australia: a population data linkage study.
Falster K; Banks E; Lujic S; Falster M; Lynch J; Zwi K; Eades S; Leyland AH; Jorm L
BMC Pediatr; 2016 Oct; 16(1):169. PubMed ID: 27769208
[TBL] [Abstract][Full Text] [Related]
14. Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-up.
Vila-Corcoles A; Ochoa-Gondar O; Rodriguez-Blanco T; Gutierrez-Perez A; Vila-Rovira A; Gomez F; Raga X; de Diego C; Satue E; Salsench E;
BMC Public Health; 2012 Mar; 12():222. PubMed ID: 22436146
[TBL] [Abstract][Full Text] [Related]
15. Pediatric hospital admissions in Indigenous children: a population-based study in remote Australia.
Dossetor PJ; Martiniuk ALC; Fitzpatrick JP; Oscar J; Carter M; Watkins R; Elliott EJ; Jeffery HE; Harley D
BMC Pediatr; 2017 Nov; 17(1):195. PubMed ID: 29166891
[TBL] [Abstract][Full Text] [Related]
16. High pneumonia lifetime-ever incidence in Beijing children compared with locations in other countries, and implications for national PCV and Hib vaccination.
Qu F; Weschler LB; Sun Y; Sundell J
PLoS One; 2017; 12(2):e0171438. PubMed ID: 28166256
[TBL] [Abstract][Full Text] [Related]
17. Effect of Haemophilus influenzae Type b and 13-Valent Pneumococcal Conjugate Vaccines on Childhood Pneumonia Hospitalizations and Deaths in Botswana.
Congdon M; Hong H; Young RR; Cunningham CK; Enane LA; Arscott-Mills T; Banda FM; Chise M; Motlhatlhedi K; Feemster K; Patel SM; Boiditswe S; Leburu T; Shah SS; Steenhoff AP; Kelly MS
Clin Infect Dis; 2021 Jul; 73(2):e410-e416. PubMed ID: 32634831
[TBL] [Abstract][Full Text] [Related]
18. Association between regular physical activity and pneumonia-related hospitalization according to pneumococcal vaccination status: The VENUS study.
Murata F; Maeda M; Ono R; Fukuda H
Vaccine; 2024 Feb; 42(6):1268-1274. PubMed ID: 38281899
[TBL] [Abstract][Full Text] [Related]
19. Influenza and pneumococcus vaccination rates in pediatric dialysis patients in Europe: recommendations vs reality A European Pediatric Dialysis Working Group and European Society for Pediatric Nephrology Dialysis Working Group study.
Atikel YÖ; Bakkaloğlu SA; Paglialonga F; Stefanidis CJ; Askiti V; Vidal E; Ariceta G; Melek E; Verrina E; Printza N; Vondrak K; Zurowska A; Zagozdzon I; Ekim M; Özmert EN; Dufek S; Jankauskiene A; Schmitt CP; Levai E; Walle JV; Canpolat N; Holtta T; Fischbach M; Zaloszyc A; Klaus G; Aufricht C; Shroff R; Edefonti A
Turk J Med Sci; 2021 Dec; 51(6):2881-2886. PubMed ID: 33535736
[TBL] [Abstract][Full Text] [Related]
20. Associations between gestational age at birth and infection-related hospital admission rates during childhood in England: Population-based record linkage study.
Coathup V; Carson C; Kurinczuk JJ; Macfarlane AJ; Boyle E; Johnson S; Petrou S; Quigley MA
PLoS One; 2021; 16(9):e0257341. PubMed ID: 34555039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
